Antibiotic Cubicin Linked to Eosinophilic Pneumonia

Jul 30, 10 Antibiotic Cubicin Linked to Eosinophilic Pneumonia

Share The U.S. FDA announced that patients taking care of with Cubicin, an intravenous antibiotic, sprint an augmented threat of rising eosinophilic pneumonia, a uncommon and potentially life-threatening situation. Cubicin is the trade name for the generic medicine daptomycin. The medicine was first permitted in 2003 for taking care...

read more